Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

/CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-Mâ„¢ adjuvant, announced that it has filed for...

NVAX : 12.97 (+1.89%)
Where Will Novavax Be in 1 Year?

We will know a lot more about the vaccine maker's long-term prospects in 12 months.

NVAX : 12.97 (+1.89%)
SNY : 48.54 (-2.12%)
Is It Too Late to Buy Novavax Stock?

Shares of the vaccine maker are trading up 230% this year.

NVAX : 12.97 (+1.89%)
SNY : 48.54 (-2.12%)
Bull Market and Beyond: 3 Stocks Just Waiting to Soar

These pharma and biotech players could become long-term winners.

SNY : 48.54 (-2.12%)
NVAX : 12.97 (+1.89%)
PFE : 27.83 (-1.38%)
DNA : 0.3465 (+7.21%)
Why Vaccine Stocks Rallied This Week

A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?

SNY : 48.54 (-2.12%)
MRNA : 117.07 (+0.97%)
NVAX : 12.97 (+1.89%)
BNTX : 78.76 (-0.09%)
PFE : 27.83 (-1.38%)
Better Buy: Inovio Pharmaceuticals vs. Novavax

Both biotechs have been struggling for a while, but there might be some hope for them.

PFE : 27.83 (-1.38%)
NVAX : 12.97 (+1.89%)
INO : 8.43 (-2.09%)
3 Things You Need to Know If You Buy Novavax Today

The vaccine maker's recovery story is looking brighter.

SNY : 48.54 (-2.12%)
PFE : 27.83 (-1.38%)
NVAX : 12.97 (+1.89%)
This Stock Just More Than Doubled in 1 Day: Is It a Buy?

The biotech still hasn't lost momentum.

NVAX : 12.97 (+1.89%)
SNY : 48.54 (-2.12%)
Is Novavax Stock a Buy?

Can Novavax's stock continue soaring?

NVAX : 12.97 (+1.89%)
Could Novavax Become the Next Moderna?

Sanofi believes in Novavax's vaccine strengths...

SNY : 48.54 (-2.12%)
PFE : 27.83 (-1.38%)
NVAX : 12.97 (+1.89%)
MRNA : 117.07 (+0.97%)

Barchart Exclusives

Buy This Stock to Bet on a Textbook Retail Turnaround
Ever since Richard Dickson took over as CEO in August 2023, the Gap’s results have looked like a textbook retail company recovery - sales have improved, margins expanded, and all of its brands gained market share. That's why the stock has tripled since his arrival. And there's more to come. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar